Imunon (IMNN) Receivables - Net (2011 - 2026)
Imunon's (IMNN) quarterly Receivables - Net came in at $1.8 million in Q1 2026, down 17.72% YoY from $2.2 million in Q1 2025, and down 5.96% on a QoQ basis from $1.9 million in Q4 2025.
Imunon (IMNN) Receivables - Net (2011 - 2026) Analysis & Trends
Imunon (IMNN) has 16 years of Receivables - Net data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Receivables - Net fell 17.72% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 17.72% YoY) and the FY2025 annual result came in at $1.9 million, down 9.06% from the prior year.
- Receivables - Net eased to $1.8 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $2.8 million in Q3 2022 to a low of $1.8 million in Q1 2026.
- A 5-year average of $2.4 million and a median of $2.3 million in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 54.87% — and 2023, when it declined 19.9%.
- Tracing IMNN's Receivables - Net over 5 years: stood at $2.8 million in 2022, then declined by 9.45% to $2.5 million in 2023, then fell by 12.75% to $2.2 million in 2024, then slipped by 12.51% to $1.9 million in 2025, then decreased by 5.96% to $1.8 million in 2026.
- The last three Receivables - Net figures came in at $1.8 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.53 Mn | 8.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 1.83 Mn |
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Dec 31, 2023 | 2.55 Mn |